Aurosphere® beads have a high rate and efficiency of separation of specific biomarkers with advanced chemistries. In collaboration with our medical partners, we have developed a novel assay for Acute Mesenteric Ischemia that promises to improved the quality of care for this rare but deadly disease. This screening test could save up to 75% of AMI patients if it is deployed in an emergency care clinical laboratory.